Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences [Yahoo! Finance]
Ventyx Biosciences, Inc. (VTYX)
Company Research
Source: Yahoo! Finance
that it entered into a definitive agreement to acquire Ventyx Biosciences, Inc., which is a clinical-stage biopharmaceutical company that develops innovative oral therapies for patients with inflammatory-mediated diseases. Ventyx Biosciences, Inc. is in the process of developing a pipeline of small-molecule therapeutics for the treatment of inflammation across a range of disease states with highly unmet needs, including inflammatory disorders, cardiometabolic disorders, and neurodegenerative diseases. The terms of the agreement entail that Eli Lilly and Company (NYSE:LLY) would acquire all the outstanding shares of Ventyx for $14.00 per share of common stock in an all-cash transaction, which equals an aggregate equity value of approximately $1.2 billion. Expected to close in H1 2026, the transaction is not subject to any financing condition, and is subject to approval of Ventyx stockholders and satisfaction of other customary closing conditions, which include regulatory approvals.
Show less
Read more
Impact Snapshot
Event Time:
VTYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTYX alerts
High impacting Ventyx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
VTYX
News
- Ventyx Biosciences (NASDAQ:VTYX) was downgraded by analysts at UBS Group AG from a "strong-buy" rating to a "hold" rating.MarketBeat
- Ventyx Biosciences (NASDAQ:VTYX) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.MarketBeat
- Ventyx Biosciences (NASDAQ:VTYX) was downgraded by analysts at Clear Str Llc from a "strong-buy" rating to a "hold" rating.MarketBeat
- Ventyx Biosciences (NASDAQ:VTYX) was downgraded by analysts at Lifesci Capital from a "strong-buy" rating to a "hold" rating.MarketBeat
- Ventyx Biosciences (NASDAQ:VTYX) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.MarketBeat
VTYX
Earnings
- 11/6/25 - Beat
VTYX
Sec Filings
- 1/9/26 - Form SCHEDULE
- 1/9/26 - Form SCHEDULE
- 1/8/26 - Form DEFA14A
- VTYX's page on the SEC website